The Goldman Sachs Group (NYSE:GS) Stock Price Up 0.7%

The Goldman Sachs Group, Inc. (NYSE:GS - Get Free Report)'s stock price rose 0.7% during trading on Friday . The company traded as high as $408.00 and last traded at $405.87. Approximately 650,372 shares traded hands during trading, a decline of 72% from the average daily volume of 2,345,753 shares. The stock had previously closed at $403.11.

Wall Street Analyst Weigh In

GS has been the topic of a number of recent research reports. UBS Group raised their price target on shares of The Goldman Sachs Group from $382.00 to $440.00 and gave the stock a "buy" rating in a research report on Tuesday, January 9th. Argus raised shares of The Goldman Sachs Group from a "hold" rating to a "buy" rating and set a $465.00 price target on the stock in a research report on Tuesday. Keefe, Bruyette & Woods raised their price target on shares of The Goldman Sachs Group from $445.00 to $485.00 and gave the stock an "outperform" rating in a research report on Friday, April 5th. JMP Securities raised their price target on shares of The Goldman Sachs Group from $440.00 to $460.00 and gave the stock a "market outperform" rating in a research report on Tuesday, April 9th. Finally, Daiwa Capital Markets raised shares of The Goldman Sachs Group from a "neutral" rating to an "outperform" rating and lifted their price objective for the stock from $410.00 to $430.00 in a report on Thursday, March 14th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $434.93.


Get Our Latest Report on GS

The Goldman Sachs Group Price Performance

The company has a quick ratio of 0.76, a current ratio of 1.12 and a debt-to-equity ratio of 1.98. The stock has a market cap of $131.11 billion, a P/E ratio of 15.78, a PEG ratio of 1.31 and a beta of 1.43. The firm's fifty day moving average price is $396.43 and its 200-day moving average price is $366.20.

The Goldman Sachs Group (NYSE:GS - Get Free Report) last issued its earnings results on Monday, April 15th. The investment management company reported $11.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $8.54 by $3.04. The Goldman Sachs Group had a net margin of 8.17% and a return on equity of 8.65%. The firm had revenue of $14.21 billion for the quarter, compared to analysts' expectations of $12.94 billion. During the same quarter last year, the business earned $8.79 earnings per share. The business's revenue was up 16.1% on a year-over-year basis. Analysts forecast that The Goldman Sachs Group, Inc. will post 35.15 earnings per share for the current year.

The Goldman Sachs Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 27th. Investors of record on Thursday, May 30th will be issued a $2.75 dividend. This represents a $11.00 annualized dividend and a yield of 2.72%. The ex-dividend date of this dividend is Thursday, May 30th. The Goldman Sachs Group's dividend payout ratio (DPR) is currently 42.95%.

Insider Activity at The Goldman Sachs Group

In related news, CAO Sheara J. Fredman sold 4,300 shares of The Goldman Sachs Group stock in a transaction on Tuesday, January 23rd. The shares were sold at an average price of $380.15, for a total value of $1,634,645.00. Following the sale, the chief accounting officer now owns 11,463 shares in the company, valued at $4,357,659.45. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other The Goldman Sachs Group news, CFO Denis P. Coleman sold 12,680 shares of the firm's stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $394.43, for a total transaction of $5,001,372.40. Following the completion of the transaction, the chief financial officer now owns 29,417 shares of the company's stock, valued at $11,602,947.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Sheara J. Fredman sold 4,300 shares of the firm's stock in a transaction on Tuesday, January 23rd. The shares were sold at an average price of $380.15, for a total value of $1,634,645.00. Following the transaction, the chief accounting officer now directly owns 11,463 shares of the company's stock, valued at approximately $4,357,659.45. The disclosure for this sale can be found here. Insiders have sold a total of 35,907 shares of company stock worth $13,950,851 over the last quarter. Corporate insiders own 0.54% of the company's stock.

Hedge Funds Weigh In On The Goldman Sachs Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Capital World Investors lifted its position in The Goldman Sachs Group by 6.0% during the fourth quarter. Capital World Investors now owns 6,012,564 shares of the investment management company's stock valued at $2,319,470,000 after buying an additional 338,181 shares during the period. Morgan Stanley raised its position in shares of The Goldman Sachs Group by 40.0% in the 4th quarter. Morgan Stanley now owns 5,936,351 shares of the investment management company's stock worth $2,038,425,000 after purchasing an additional 1,696,350 shares during the last quarter. Fisher Asset Management LLC raised its position in shares of The Goldman Sachs Group by 2.8% in the 4th quarter. Fisher Asset Management LLC now owns 5,518,035 shares of the investment management company's stock worth $2,128,693,000 after purchasing an additional 152,474 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of The Goldman Sachs Group by 0.5% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 5,195,203 shares of the investment management company's stock worth $2,004,153,000 after purchasing an additional 27,524 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its position in shares of The Goldman Sachs Group by 5.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 4,953,461 shares of the investment management company's stock worth $1,910,897,000 after purchasing an additional 274,989 shares during the last quarter. Hedge funds and other institutional investors own 71.21% of the company's stock.

About The Goldman Sachs Group

(Get Free Report)

The Goldman Sachs Group, Inc, a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements.

Featured Stories

Should you invest $1,000 in The Goldman Sachs Group right now?

Before you consider The Goldman Sachs Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Goldman Sachs Group wasn't on the list.

While The Goldman Sachs Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: